Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
10 Results for ''
Translation News
Cantex licenses intellectual property from Harvard University to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
February 23, 2022
Translation News
Harvard University licenses kidney engineering technology to Trestle Biotherapeutics to facilitate new kidney replacement therapies
February 22, 2022
Video/Animation
Biohybrid fish made from human cardiac cells swims like the heart beats
February 11, 2022
Translation News
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
February 10, 2022
Research Spotlights
Achieving a milestone, scientists regrow frog’s lost leg
January 26, 2022
Community
Megan Sperry on Developing Therapeutics for Traumatic Injuries
January 26, 2022
Translation News
Wyss Lumineers Class of 2021 Announced
January 24, 2022
Press Release
Landing therapeutic genes safely in the human genome
January 24, 2022
Research Spotlights
Tightening the grasp on liquid biopsies
January 6, 2022
Press Release
Towards more effective tendon repair with a multi-functional biomaterial
January 3, 2022
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
